Showing results (71-80 of 4,288) with videos related to
Sort By:
Pageof 429
European Journal of Epidemiology|May 28, 2016
The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samplesMads V Lind, Otto I Savolainen, Alastair B RossEuropean Journal of Epidemiology|May 16, 2016
Regression standardization with the R package stdRegArvid SjölanderEuropean Journal of Epidemiology|July 15, 2016
Is lipoprotein (a) protective of dementia?Setor K Kunutsor, Hassan Khan, Kristiina Nyyssönen, et al.European Journal of Epidemiology|August 14, 2017
Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult lifeBritt W Jensen, Michael Gamborg, Ismail Gögenur, et al.European Journal of Epidemiology|July 29, 2017
Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studiesSetor K Kunutsor, Ashley W Blom, Michael R Whitehouse, et al.European Journal of Epidemiology|July 28, 2017
The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screeningXabier García-Albéniz, John Hsu, Miguel A HernánEuropean Journal of Epidemiology|July 19, 2017
Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidenceSetor K Kunutsor, Samuel Seidu, Ashley W Blom, et al.European Journal of Epidemiology|September 9, 2017
Relationship of very low serum 25-hydroxyvitamin D3 levels with long-term survival in a large cohort of colorectal cancer patients from GermanyHaifa Maalmi, Viola Walter, Lina Jansen, et al.European Journal of Epidemiology|June 1, 1987
Cytopathogenicity of Entamoeba histolytica: the role of amebic adherence and contact-dependent cytolysis in pathogenesisW A Petri, J I RavdinEuropean Journal of Epidemiology|September 3, 2017
Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosisJanick Weberpals, Lina Jansen, Myrthe P P van Herk-Sukel, et al.Pageof 429